Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Ion channels regulate essential cellular functions like proliferation and apoptosis.
• Aberrant ion channel expression is linked to cancer development and drug resistance, termed "onco-channelopathy."
• Multiple myeloma (MM) is a hematological cancer driven by malignant plasma cells in the bone marrow.

Purpose of the Study:

• To review the role of ion channels and transporters in multiple myeloma.
• To highlight how ion channel deregulation promotes MM cell survival, proliferation, and drug resistance.
• To explore the potential of ion channels as therapeutic targets in MM treatment.

Main Methods:

• Literature review of studies on ion channels in multiple myeloma.
• Analysis of the impact of ion channel dysregulation on MM pathogenesis.
• Evaluation of ion channels as therapeutic targets in MM.

Main Results:

• Ion channel deregulation significantly contributes to MM progression.
• Targeting ion channels can modulate intracellular pathways crucial for MM cell survival and proliferation.
• Ion channels play a role in MM drug resistance.

Conclusions:

• Ion channels are critical regulators of multiple myeloma.
• Targeting ion channels presents a promising therapeutic avenue for MM.
• Combination strategies involving ion channel modulators could improve MM treatment outcomes and reduce side effects.